Since its discovery in 1975, we now have a wealth of knowledge relating to the biochemical, pharmacological and physiological actions of thromboxane A2 (TXA2) and its related metabolites. These molecular insights have been greatly expedited by the molecular cloning and characterization of a cDNA for the human TXA2 receptor, now termed the T Prostanoid or TP receptor, from a megakaryocytic/placental cDNA library in 1991, and later through the discovery of a cDNA encoding a second isoform of the human TP receptor in 1994. The requirement for two TP receptors in primates, but not in other species thus far investigated, is unclear, but points to potential species-specific physiological differences. In this review, I will describe some recent advances in the research field of TXA2/TP receptor signalling, focusing particularly on studies pertaining to the human TP receptor isoforms.
Skip Nav Destination
Article navigation
November 2001
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Conference Article|
November 01 2001
Thromboxane A2 Signalling in Humans: a ‘Tail’ of Two Receptors
B. T. Kinsella
B. T. Kinsella
1
1Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, Merville House, University College Dublin, Belfield, Dublin 4, Ireland
1e-mail Therese.Kinsella@UCD.ie
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2001 Biochemical Society
2001
Biochem Soc Trans (2001) 29 (6): 641–654.
Citation
B. T. Kinsella; Thromboxane A2 Signalling in Humans: a ‘Tail’ of Two Receptors. Biochem Soc Trans 1 November 2001; 29 (6): 641–654. doi: https://doi.org/10.1042/bst0290641
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.